endogen
compound
often
use
basi
structur
compon
pharmacolog
prepar
exampl
indirubin
activ
ingredi
danggui
longhui
wan
mixtur
plant
use
tradit
chines
medicin
treat
chronic
diseas
hoessel
et
al
also
individu
chines
medicin
herb
isati
indigotica
strobilanth
cusia
mak
et
al
indirubin
deriv
potent
inhibitor
cyclin
depend
kinas
pharmacolog
import
kinas
indirubin
may
form
dimer
isatin
figur
anoth
biolog
activ
compound
attract
much
interest
pharmacologist
isatin
indoledion
endogen
indol
found
mammalian
brain
peripher
tissu
bodi
fluid
see
review
medvedev
et
al
glover
et
al
medvedev
glover
medvedev
igosheva
et
al
isatin
moieti
also
present
rang
compound
act
inhibitor
apoptosi
lee
et
al
chapman
et
al
anticonvuls
verma
et
al
antivir
sriram
et
al
pirrung
et
al
antibacteri
antifung
chohan
et
al
agent
possibl
drug
contain
isatin
moieti
may
compet
endogen
isatin
latter
influenc
therapeut
effect
consequ
analysi
isatin
content
bodi
metabol
rout
interact
may
import
understand
function
endogen
regul
also
understand
possibl
role
function
agonistantagonist
drug
review
discuss
wide
rang
biolog
target
known
sensit
isatin
analogu
evid
endogen
isatin
may
affect
respons
isatin
origin
identifi
one
compon
endogen
monoamin
oxidas
mao
inhibitori
activ
tribulin
glover
et
al
isatin
concentr
blood
exceed
manab
et
al
mawatari
et
al
igosheva
et
al
base
tissu
isatin
watkin
et
al
water
reinoso
et
al
content
calcul
basal
isatin
tissu
concentr
differ
variou
organ
tabl
highest
concentr
brain
hippocampu
cerebellum
striatum
wherea
peripher
organ
highest
concentr
semin
vesicl
va
deferen
heart
maxim
basal
concentr
approach
rat
organ
basal
isatin
concentr
vari
spleen
liver
rat
stress
caus
fold
increas
isatin
content
brain
heart
igosheva
et
al
fold
increas
isatin
output
urin
tozawa
et
al
concentr
serum
reach
igosheva
et
al
suggest
certain
condit
isatin
concentr
may
high
even
take
consider
except
high
concentr
semin
vesicl
va
deferen
although
pathway
endogen
isatin
format
see
figur
still
requir
better
experiment
support
vitro
evid
isatin
form
indol
typic
produc
tryptophan
catabol
gut
involv
microsom
cytochrom
gillam
et
al
besid
excret
urin
catabol
pathway
isatin
includ
possibl
spontan
oxid
dimer
yield
indigoid
pigment
indigo
indirubin
medvedev
et
al
gillam
et
al
hydrogen
peroxidedepend
convers
anthranil
acid
medvedev
glover
nadphdepend
reduct
usami
et
al
compound
found
urin
usami
et
al
medvedev
glover
howev
remain
unclear
whether
indigoid
format
preced
urinari
excret
aerob
transform
urinari
compon
interestingli
vitro
oxid
indol
cytochrom
enzym
isatin
intermedi
transform
indigoid
pigment
major
end
product
gilliam
et
al
studi
isatin
content
convent
germfre
rat
shown
least
basal
isatin
urinari
tissu
level
larg
produc
gut
flora
urinari
isatin
level
germ
free
rat
time
lower
sampl
convent
rat
similar
concentr
tissu
sandler
et
al
suggest
gut
flora
import
role
product
urinari
isatin
least
rat
pyruv
kinas
pk
ec
import
glycolyt
enzym
catalys
reaction
phosphoryl
group
transfer
phosphoenolpyruv
adp
reaction
substrat
phosphoryl
phosphoenolpyruv
adp
enol
pyruv
atp
rabbit
muscl
pyruv
kinas
isoform
also
present
brain
tsutsumi
et
al
yamada
noguchi
bind
isatin
kd
valu
upper
physiolog
rang
isatin
concentr
buneeva
et
al
interact
appear
specif
enzym
class
creatin
kinas
ec
exhibit
concentr
depend
bind
isatin
buneeva
et
al
pyruv
kinas
interact
isatin
sensit
inhibit
atp
neuroprotect
prepar
deprenyl
although
biolog
role
interact
fulli
understood
may
phenomenon
underli
nonglycolyt
function
enzym
buneeva
et
al
inde
certain
evid
exist
pyruv
kinas
factor
regul
cytoskelet
protein
et
al
et
al
also
involv
resist
glial
cell
hypoxia
shimizu
et
al
dehydrogenas
gapdh
ec
classic
glycolyt
enzym
exhibit
divers
nonglycolyt
function
depend
subcellular
local
gapdh
specif
interact
differ
rna
vivo
vitro
nagi
rigbi
de
et
al
lin
et
al
yi
et
al
evguenievahackenberg
et
al
may
cleav
evguenievahackenberg
et
al
overexpress
gapdh
subsequ
nuclear
transloc
implic
initi
one
apoptot
cascad
also
aetiolog
neurolog
diseas
tatton
et
al
berri
transloc
gapdh
nucleu
import
event
lead
apoptosi
tatton
et
al
berri
especi
neuron
cell
increas
evid
gapdh
may
serv
target
smallmolecul
antiapoptot
compound
slowingprev
progress
neurodegen
disord
ishitani
et
al
berri
gapdh
thu
promis
target
variou
neuroprotect
drug
good
evid
exist
bind
deprenyl
initi
introduc
mechanismbas
mao
b
inhibitor
propargylamin
gapdh
primarili
respons
neuroprotect
antiapoptot
effect
substanc
carlil
et
al
kragten
et
al
maruyama
et
al
tatton
et
al
berri
besid
pharmacolog
substanc
gapdh
also
bind
isatin
medvedev
et
al
kd
valu
determin
two
independ
method
respect
within
upper
physiolog
limit
isatin
concentr
interact
rel
specif
anoth
oligomer
cytosol
naddepend
enzym
lactat
dehydrogenas
bind
immobil
isatin
analogu
medvedev
et
al
bind
gapdh
isatin
weakli
influenc
glycolyt
activ
enzym
inhibit
gapdhmedi
cleavag
e
coli
trna
highli
purifi
rabbit
muscl
gpdh
effect
bind
isatin
analogu
immobilis
cuvett
iasi
optic
biosensor
buneeva
et
al
replac
cuvett
medium
wash
buffer
caus
total
dissoci
gpdhisatin
complex
suggest
involv
sever
type
enzymeisatin
interact
includ
tight
bind
although
concentr
isatin
caus
differ
effect
gpdh
activ
former
significantli
increas
appar
km
nad
wherea
latter
decreas
appar
vmax
increas
km
possibl
biolog
signific
regul
remain
unclear
ubiquitin
highli
conserv
kda
protein
coval
attach
lysin
residu
target
protein
ubiquitin
conjug
system
metabol
pathway
often
use
select
proteasom
degrad
mani
shortliv
protein
eukaryot
cell
ubiquitinmedi
degrad
regulatori
protein
play
import
role
control
numer
process
includ
cellcycl
progress
signal
transduct
transcript
regul
receptor
downregul
endocytosi
hershko
ciechanov
ubiquitin
system
involv
immun
respons
develop
program
cell
death
abnorm
ubiquitinmedi
process
may
caus
develop
variou
patholog
condit
includ
malign
transform
hershko
ciechanov
hoeller
et
al
system
lupu
erythematosu
juri
et
al
autoimmun
diseas
jiang
et
al
parkinson
diseas
dawson
buneeva
medvedev
etc
recent
demonstr
ubiquitin
bind
isatin
analogu
immobil
biacor
cell
buneeva
et
al
prepar
although
kd
valu
mm
rather
high
phenomenon
may
implic
ubiquitin
interact
isatin
analogu
see
natriuret
peptid
famili
relat
compound
includ
atrial
natriuret
peptid
anp
brain
natriuret
peptid
bnp
ctype
natriuret
peptid
cnp
peptid
receptor
repres
import
regulatori
system
anandsrivastava
tracht
potter
et
al
involv
regul
fluid
homeostasi
blood
pressur
also
regul
emot
behavior
eg
anxieti
arous
alter
stress
hormon
releas
autonom
nervou
system
activ
wiedemann
et
al
natriuret
peptid
interact
three
type
membran
receptor
two
natriuret
peptid
receptor
type
npra
natriuret
peptid
receptor
type
b
nprb
transmembran
glycoprotein
exhibit
liganddepend
intrins
guanylyl
cyclas
activ
anandsrivastava
tracht
silberbach
robert
misono
tracht
potter
et
al
anp
bnp
bind
preferenti
npra
wherea
cnp
exhibit
much
higher
affin
nprb
third
receptor
natriuret
peptid
receptor
type
c
nprc
lack
cyclas
domain
bind
three
peptid
nprc
receptor
coupl
adenylyl
cyclas
inhibit
inhibitori
guanin
nucleotideregul
protein
anandsrivastava
tracht
silberbach
robert
misono
tracht
potter
et
al
isatin
inhibit
anp
bind
guinea
pig
cerebellar
membran
glover
et
al
within
lower
limit
physiolog
rang
isatin
concentr
anp
cnp
inhibit
isatinbind
rat
brain
section
isol
membran
fraction
valu
anp
effect
medvedev
crumeyrollearia
et
al
close
correspond
effect
isatin
anp
bind
isatin
also
inhibit
rat
brain
particul
guanylyl
cyclas
activ
stimul
anp
bnp
medvedev
et
al
suggest
involv
npra
recent
report
isatin
situ
block
effect
anp
hyperpolarizationactiv
current
human
atrial
myocyt
involv
cyclic
gmp
signal
lonardo
et
al
latter
provid
experiment
evid
isatin
interact
npra
isatin
administr
block
cyclic
gmp
excret
condit
fluid
overload
known
induc
endogen
anp
releas
medvedev
et
al
provid
evid
isatin
antagonis
npra
signal
vivo
inde
perfus
isatin
administr
abort
protect
effect
atrial
natriuret
peptid
administ
prior
reperfus
evalu
limit
infarct
rabbit
heart
yang
et
al
isatin
administr
shown
block
cyclic
gmp
excret
condit
fluid
overload
known
induc
endogen
anp
releas
medvedev
et
al
provid
evid
isatin
antagonis
npra
signal
vivo
high
concentr
isatin
may
also
inhibit
natriuret
peptid
signal
associ
nprc
medvedev
crumeyrollearia
et
al
consist
isatin
inhibit
anp
bnp
cnpinduc
behavior
effect
bhattacharya
et
al
telegdi
et
al
pataki
et
al
three
major
natriuret
peptid
act
common
one
type
natriuret
peptid
receptor
type
c
nprc
anandsrivastava
tracht
silberbach
robert
misono
et
al
potter
et
al
potter
et
al
report
pretreat
isatin
bilater
abolish
effect
bremazocin
receptor
agonist
caus
enhanc
total
outflow
facil
enhanc
level
natriuret
peptid
anp
bnp
cnp
aqueou
humor
evid
suggest
isatin
antagon
natriuret
peptid
receptor
situ
vivo
besid
membran
bound
gualyl
cyclas
coupl
natriuret
peptid
receptor
solubl
guanyl
cyclas
enzym
catalyz
cgmp
format
gtp
enzym
activ
form
larginin
nitric
oxid
synthas
variou
donor
includ
employ
clinic
luscher
keefer
napoli
ignarro
enzym
play
import
role
vasodil
ignarro
et
al
ignarro
shown
basal
activ
human
platelet
guanyl
cyclas
sensit
isatin
wherea
nostimul
activ
inhibit
low
physiolog
concentr
isatin
rang
medvedev
et
al
subsequ
increas
isatin
concentr
accompani
clear
decreas
effect
unidirect
regul
particul
npra
solubl
guanyl
cyclas
differ
rang
isatin
concentr
suggest
import
stressinduc
switch
metabol
process
sensit
cgmpdepend
control
medvedev
et
al
enzym
exist
isoform
activ
via
phosphoryl
activ
erk
phosphoryl
cytoplasm
membran
nuclear
substrat
requir
sequenti
transit
cell
cycl
phase
particularli
transit
chambard
et
al
treatment
cell
isatin
reduc
erk
activ
significantli
reduc
phosphryl
isoform
cane
et
al
isatin
induc
cell
death
includ
apoptosi
tumor
cell
howev
molecular
target
respons
effect
remain
unknown
igosheva
et
al
shown
isatin
increas
apoptosi
dopaminerg
neuroblastoma
cell
higher
isatin
concentr
cell
die
via
necrosi
cane
et
al
observ
antiprolif
effect
isatin
tumor
human
promyelocyt
leukemia
cell
rat
adren
pheochromocytoma
cell
mous
neuroblastoma
cell
normal
cell
mous
fibroblast
cell
bovin
brain
capillari
bbc
cell
effect
concentr
requir
effect
upper
limit
physiolog
concentr
higher
studi
cell
cultur
low
serum
concentr
sourc
growth
factor
remain
determin
whether
normal
andor
tumor
cell
would
similarli
vulner
isatin
inhibit
nitric
oxid
product
raw
macrophag
cell
activ
mixtur
lipopolysaccharid
lp
interferon
dose
depend
manner
also
inhibit
product
prostaglandin
tumor
necrosi
factor
matheu
et
al
inhibit
product
obvious
associ
isatin
effect
express
induc
nitric
oxid
synthas
respect
demonstr
western
blot
analysi
matheu
et
al
isatin
analogu
possess
variou
substitu
rr
r
see
figur
activ
sar
coronaviru
proteas
belong
famili
serin
proteas
import
target
design
drug
treatment
new
viral
atyp
pneumonia
known
sever
acut
respiratori
syndrom
sar
valu
within
concentr
rang
chen
et
al
effect
activ
compound
test
highli
specif
inhibit
serin
proteas
trypsin
chymotrypsin
papain
cystein
proteas
observ
much
higher
concentr
mm
chen
et
al
nsubstitut
isatin
deriv
isatin
inhibit
parasit
cystein
proteas
identifi
trypanosom
cruzain
rhodesain
malaria
parasit
chiyanzu
et
al
webber
et
al
synthes
isatinbas
inhibitor
human
rhinoviru
proteas
viral
enzym
absolut
requir
proteolyt
cleavag
viral
precursor
polyprotein
function
protein
wanga
chen
simpl
nsubstitut
isatin
analogu
ncarbobenzyloxi
isatin
act
slow
bind
inhibitor
chymotrypsin
porcin
elastas
iyer
hanna
nsubstitut
isatin
contain
complex
substitu
effect
inhibit
human
serin
proteas
chymotrypsin
leukocyt
elastas
plasmin
shuttleworth
et
al
caspas
famili
cysteinedepend
aspartatedirect
proteas
least
caspas
known
date
play
signific
role
apoptosi
inflamm
earnshaw
et
al
yuan
yankner
troy
salvesen
caspas
function
upstream
initi
proteolyt
cascad
downstream
effector
caspas
chowdhuri
et
al
recent
studi
suggest
caspas
also
involv
mani
physiolog
process
immun
cell
differenti
cell
cycl
regulatori
mechan
nervou
tissu
etc
timmer
salversen
kuranada
miura
numer
data
show
caspas
cascad
take
part
dysfunct
death
neuron
neurodegen
disord
includ
alzheim
parkinson
hantington
diseas
earnshaw
et
al
troy
salvesen
jelling
mattson
mehta
et
al
increas
evid
caspas
substrat
serv
molecular
target
damag
mechan
pathogenesi
cardiovascular
dysfunct
autoimmun
autoinflammatori
diseas
variou
form
cancer
rheumat
ophthalmolog
dysfunct
mani
diseas
guttenplan
et
al
hajira
et
al
stoneman
bennett
hinter
et
al
jin
eldeiri
de
thonel
et
al
rose
martin
reev
et
al
vermeulen
et
al
siegel
timmer
salversen
testa
riccioni
simpl
isatin
analogu
effect
inhibit
ki
ki
ki
lee
et
al
specif
isatin
sulfonamid
inhibitor
inhibit
ki
nm
respect
compound
exhibit
greater
select
highli
homolog
vs
famili
member
except
ki
nm
lee
et
al
isatin
sulfonamid
select
caspas
inhibitor
block
apoptosi
murin
bone
marrow
neutrophil
human
chondrocyt
lee
et
al
prevent
abil
bisphosphon
caspas
activ
zoledron
acid
clodron
alendron
caus
characterist
chang
nuclear
morpholog
rabbit
osteoclast
associ
apoptosi
benford
et
al
pyrrolidin
azetidin
isatin
also
act
caspas
inhibitor
exhibit
high
inhibitori
potenc
nm
nm
protein
kinas
constitut
larg
famili
potenti
target
varieti
diseas
cyclindepend
kinas
cdk
posit
regul
cell
cycl
progress
morgan
key
regul
embryon
develop
cancer
sever
cdk
inhibitori
drug
variou
stage
clinic
trial
antitumor
agent
senderowicz
evid
cyclindepend
kinas
cdk
major
regul
cell
immun
toler
see
review
rowel
well
well
enzym
repres
novel
potenti
target
therapi
autoimmun
diseas
organ
transplant
evid
indirubin
origin
dimer
isatin
see
figur
deriv
potent
inhibitor
hoessel
et
al
leclerc
et
al
indirubin
exhibit
strong
affin
cdk
valu
rang
nm
hoessel
et
al
leclerc
et
al
kinas
csrc
tyrosin
kinas
casein
kinas
insulin
receptor
tyrosin
kinas
campdepend
protein
kinas
cgmpdepend
protein
kinas
protein
kinas
c
craf
mapk
erk
exhibit
much
lower
sensit
valu
hoessel
et
al
substitut
indirubin
produc
escherichia
coliexpress
human
mutant
cultiv
presenc
inhibit
human
valu
glycogen
synthas
guengerich
et
al
indirubin
effect
inhibit
glycogen
synthas
valu
nm
rang
leclerc
et
al
kinas
involv
multipl
physiolog
process
includ
cell
cycl
regul
control
level
cyclin
diehl
et
al
yost
et
al
insulin
effect
glycogen
synthesi
cohen
summer
et
al
axon
outgrowth
luca
et
al
tat
mediat
neurotox
maggirwar
et
al
etc
respons
abnorm
hyperphosphoryl
microtubulebind
protein
tau
observ
pair
helic
filament
diagnost
alzheim
diseas
ad
imahori
uchida
mandelkow
mandelkow
thu
indirubin
may
constitut
lead
compound
studi
treatment
neurodegen
disord
endogen
activ
erk
significantli
decreas
treatment
isatin
activ
inhibit
concentrationdepend
manner
endogen
compound
concentr
mm
necessari
obtain
signific
inhibit
isatin
respect
activ
isatin
inhibit
phosphoryl
effect
appear
rather
select
compound
influenc
phosphoryl
cane
revers
transcriptas
catalyz
reaction
dna
synthesi
rna
templat
consid
promis
target
antihiv
drug
de
clerq
pauwel
aminopyrimidinimino
isatin
deriv
inhibit
replic
hiv
type
lymphocyt
cem
cell
line
especi
cell
howev
effect
significantli
lower
refer
standard
nevirapin
sriram
et
al
although
vitro
assay
reveal
compound
possess
activ
inhibit
revers
transcriptas
valu
concentr
requir
inhibit
sever
time
higher
effect
concentr
requir
inhibit
cytopath
effect
cell
cultur
sriram
et
al
twelv
isatin
deriv
seri
also
activ
hepat
c
viru
hcv
rna
replic
show
inhibit
howev
biolog
target
respons
effect
investig
sriram
et
al
nmethylisatin
methisazon
marboran
effect
prophylaxi
smallpox
sever
trial
epidem
methisazon
reduc
attack
rate
de
clerq
isatin
inhibit
vaccina
viru
multipl
chicken
embryo
kidney
cell
hela
cell
valu
case
virus
monkeypox
viru
variola
viru
valu
higher
mechan
action
isatin
remain
clarifi
certain
evid
exist
influenc
viral
matur
de
clerq
nmethyl
isatin
meibt
inhibit
rou
sarcoma
viru
rnadepend
dna
polymeras
wherea
combin
caus
minor
inhibit
caus
nearli
total
inhibit
enzym
activ
levinson
et
al
isatin
analogu
inhibit
product
nitric
oxid
raw
macrophag
cell
activ
mixtur
lipopolysaccharid
lp
interferon
matheu
et
al
howev
effect
insignificantli
differ
effect
isatin
case
isatin
inhibit
product
obvious
associ
isatin
effect
express
induc
nitric
oxid
synthas
respect
demonstr
western
blot
analysi
matheu
et
al
product
activ
cell
decreas
isatin
studi
exhibit
highest
effect
matheu
et
al
author
suggest
isatin
analogu
may
chemoprevent
activ
malign
process
downregul
andor
ino
matheu
et
al
carboxylesteras
ubiquit
enzym
involv
metabol
variou
xenobiot
includ
drug
employ
clinic
eg
demerol
lidocain
capecitabin
lohr
et
al
hyatt
et
al
isatin
analogu
contain
hydrophob
group
attach
varieti
posit
within
molecul
exhibit
potent
specif
inhibit
carboxylesteras
ki
valu
nm
rang
hyatt
et
al
author
believ
isatin
analogu
may
consid
lead
compound
develop
inhibitor
modul
drug
metabol
vivo
although
interact
isatin
analogu
drug
specif
biolog
target
still
requir
detail
analysi
evid
isatin
protect
mao
b
irrevers
inhibiton
mechan
base
inhibitor
phenelzin
panova
et
al
pargylin
medvedev
et
al
unpublish
observ
deprenyl
turn
inhibit
isatin
bind
gapdh
effect
rather
specif
mechan
base
mao
inhibitor
tranylcypromin
ineffect
medvedev
et
al
deprenyl
somewhat
effect
inhibit
rnase
activ
gapdh
isatin
combin
addit
effect
rnase
inhibit
somewhat
less
pronounc
case
independ
action
deprenyl
medvedev
et
al
thu
possibl
less
effect
pharmacolog
drug
deprenyl
isatin
may
attenu
effect
lesser
extent
nmethylisatin
inhibit
ubiquitin
bind
aminoisatin
immobil
onto
cuvett
optic
biosensor
biacor
buneeva
et
al
prepar
latter
suggest
endogen
isatin
may
attenu
interact
biolog
target
drug
contain
isatin
moieti
therefor
influenc
expect
therapeut
effect
isatin
analogu
act
larg
number
biolog
target
wide
varieti
actual
potenti
pharmacolog
action
evid
isatin
may
attenu
effect
certain
pharmaceut
agent
specif
biolog
target
monoamin
oxidas
inhibitor
andor
neuroprotect
drug
panova
et
al
medvedev
et
al
isatin
present
blood
micromolar
rang
increas
respons
stress
igosheva
et
al
suggest
endogen
isatin
possibl
precursor
metabolit
may
affect
sensit
biolog
target
therapeut
employ
rang
diseas
disord
